The Role of PPARs in Cancer

被引：195
作者：
Tachibana, Keisuke [1 ]
Yamasaki, Daisuke [1 ,2 ]
Ishimoto, Kenji [1 ,3 ]
Doi, Takefumi [1 ,2 ,3 ]
机构：
[1] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan
[3] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan
来源：
PPAR RESEARCH | 2008年 / 2008卷
关键词：
D O I：
10.1155/2008/102737
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that belong to the nuclear hormone receptor superfamily. PPAR alpha is mainly expressed in the liver, where it activates fatty acid catabolism. PPAR alpha activators have been used to treat dyslipidemia, causing a reduction in plasma triglyceride and elevation of high-density lipoprotein cholesterol. PPAR delta is expressed ubiquitously and is implicated in fatty acid oxidation and keratinocyte differentiation. PPAR delta activators have been proposed for the treatment of metabolic disease. PPAR gamma 2 is expressed exclusively in adipose tissue and plays a pivotal role in adipocyte differentiation. PPAR gamma is involved in glucose metabolism through the improvement of insulin sensitivity and represents a potential therapeutic target of type 2 diabetes. Thus PPARs are molecular targets for the development of drugs treating metabolic syndrome. However, PPARs also play a role in the regulation of cancer cell growth. Here, we review the function of PPARs in tumor growth. Copyright (C) 2008 Keisuke Tachibana et al.
引用
收藏
页数：15
相关论文
共 195 条
[61]   Formation, prevention, and repair of DNA damage by iron hydrogen peroxide [J].
Henle, ES ;
Linn, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (31) :19095-19098
[62]   MODE OF ACTION OF PEROXISOME PROLIFERATORS AS HYPOLIPIDEMIC DRUGS - SUPPRESSION OF APOLIPOPROTEIN C-III [J].
HERTZ, R ;
BISHARASHIEBAN, J ;
BARTANA, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (22) :13470-13475
[63]   NATURE OF HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN RAT [J].
HESS, R ;
STAUBLI, W ;
RIESS, W .
NATURE, 1965, 208 (5013) :856-+
[64]  
Hisatake J, 2000, CANCER RES, V60, P5494
[65]   Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands do not potentiate growth of human cancer cell lines [J].
Hollingshead, Holly E. ;
Killins, Renee L. ;
Borland, Michael G. ;
Girroir, Elizabeth E. ;
Billin, Andrew N. ;
Willson, Timothy M. ;
Sharma, Arun K. ;
Amin, Shantu ;
Gonzalez, Frank J. ;
Peters, Jeffrey M. .
CARCINOGENESIS, 2007, 28 (12) :2641-2649
[66]   A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator-activated receptor DNA binding [J].
Hsu, MH ;
Palmer, CNA ;
Song, W ;
Griffin, KJ ;
Johnson, EF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (43) :27988-27997
[67]   Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor a in HepG2 cells [J].
Hsu, MH ;
Savas, V ;
Griffin, KJ ;
Johnson, EF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (30) :27950-27958
[68]   Liver fatty acid-binding protein targets fatty acids to the nucleus - Real time confocal and multiphoton fluorescence imaging in living cells [J].
Huang, H ;
Starodub, O ;
McIntosh, A ;
Kier, AB ;
Schroeder, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (32) :29139-29151
[69]   Liver fatty acid-binding protein colocalizes with peroxisome proliferator activated receptor α and enhances ligand distribution to nuclei of living cells [J].
Huang, H ;
Starodub, O ;
McIntosh, A ;
Atshaves, BP ;
Woldegiorgis, G ;
Kier, AB ;
Schroeder, F .
BIOCHEMISTRY, 2004, 43 (09) :2484-2500
[70]   In vivo activation of PPAR target genes by RXR homodimers [J].
IJpenberg, A ;
Tan, NS ;
Gelman, L ;
Kersten, S ;
Seydoux, J ;
Xu, JM ;
Metzger, D ;
Canaple, L ;
Chambon, P ;
Wahli, W ;
Desvergne, B .
EMBO JOURNAL, 2004, 23 (10) :2083-2091
234567891011